Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001181431-14-037478
Filing Date
2014-12-01
Accepted
2014-12-01 09:02:13
Documents
2
Period of Report
2014-11-25

Document Format Files

Seq Description Document Type Size
1 FORM 3 rrd419443.html 3  
1 FORM 3 rrd419443.xml 3 1475
2 rrd377694_427902.htm EX-24. 2961
  Complete submission text file 0001181431-14-037478.txt   5803
Mailing Address C/O BIOMARIN PHARMACEUTICAL INC. 105 DIGITAL DRIVE NOVATO CA 94949
Business Address
BAFFI ROBERT (Reporting) CIK: 0001274826 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35798 | Film No.: 141256452

Mailing Address 442 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 442 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080 650.243.3100
KALOBIOS PHARMACEUTICALS INC (Issuer) CIK: 0001293310 (see all company filings)

EIN.: 770557236 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations